Deep Brain Stimulation | Surgery, Brain pacemaker, Brain, Chronic pain, Tremor, Dystonia, Blind experiment, Food and Drug Administration (United States), Essential tremor, Parkinson's disease, Major depressive disorder

Frederic P. Miller (u. a.)

ISBN 10: 6130687257 / ISBN 13: 9786130687250

Published by OmniScriptum, 2026

About this Item

Deep Brain Stimulation | Surgery, Brain pacemaker, Brain, Chronic pain, Tremor, Dystonia, Blind experiment, Food and Drug Administration (United States), Essential tremor, Parkinson's disease, Major depressive disorder | Frederic P. Miller (u. a.) | Taschenbuch | Englisch | 2026 | OmniScriptum | EAN 9786130687250 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.

Seller Inventory # 113237871

Bibliographic Details

• Title: Deep Brain Stimulation | Surgery, Brain pacemaker, Brain, Chronic pain, Tremor, Dystonia, Blind experiment, Food and Drug Administration (United States), Essential tremor, Parkinson's disease, Major depressive disorder
• Publisher: OmniScriptum
• Publication Date: 2026
• Language: English
• ISBN 10: 6130687257
• ISBN 13: 9786130687250
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 10D millimeters 220 millimeters width by 150 millimeters height by 10 millimeters depth
• Weight: 256 grams
• Seller catalogs:
  • Bücher

About this title

Synopsis

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Deep brain stimulation (DBS) is a surgical treatment involving the implantation of a medical device called a brain pacemaker, which sends electrical impulses to specific parts of the brain. DBS in select brain regions has provided remarkable therapeutic benefits for otherwise treatment-resistant movement and affective disorders such as chronic pain, Parkinson’s disease, tremor and dystonia. Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques) and is one of only a few neurosurgical methods that allows blinded studies. The Food and Drug Administration (FDA) approved DBS as a treatment for essential tremor in 1997, for Parkinson's disease in 2002, and dystonia in 2003. DBS is also routinely used to treat chronic pain and has been used to treat various affective disorders, including major depression. While DBS has proven helpful for some patients, there is potential for serious complications and side effects.